Chenyu Lin

867 total citations
40 papers, 524 citations indexed

About

Chenyu Lin is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Chenyu Lin has authored 40 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Hematology and 8 papers in Genetics. Recurrent topics in Chenyu Lin's work include Chronic Myeloid Leukemia Treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and CAR-T cell therapy research (5 papers). Chenyu Lin is often cited by papers focused on Chronic Myeloid Leukemia Treatments (6 papers), Chronic Lymphocytic Leukemia Research (5 papers) and CAR-T cell therapy research (5 papers). Chenyu Lin collaborates with scholars based in United States, Taiwan and Italy. Chenyu Lin's co-authors include Joseph Tung‐Chieh Chang, Ching‐Jiunn Tseng, C C Pao, C. Sternberg, Daniel P. Petrylak, Susan Halabi, Liji Shen, Eric J. Small, Andrew J. Armstrong and Ellen B. Kaplan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Chenyu Lin

33 papers receiving 512 citations

Peers

Chenyu Lin

ONCOL

PRM

SURGE

OTORH

Wenlan Zhou China

Anne Kathrin Höhn Germany

Tamara Rordorf Switzerland

Masakuni Sakaguchi Japan

Cheng-Hsu Wang Taiwan

Milan Vošmik Czechia

Yoshihito Nomoto Japan

Naoya Ishibashi Japan

P Hausner United States

Reinhardt J. Kau Germany

Wenlan Zhou China

Chenyu Lin

220 ×1.2

ONCOL

124 ×0.7

PRM

159 ×1.1

SURGE

123 ×1.0

29 ×0.3

OTORH

Citations per year, relative to Chenyu Lin Chenyu Lin (= 1×) peers Wenlan Zhou

Countries citing papers authored by Chenyu Lin

Since Specialization

Citations

This map shows the geographic impact of Chenyu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenyu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenyu Lin more than expected).

Fields of papers citing papers by Chenyu Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenyu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenyu Lin. The network helps show where Chenyu Lin may publish in the future.

Co-authorship network of co-authors of Chenyu Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chenyu Lin. A scholar is included among the top collaborators of Chenyu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenyu Lin. Chenyu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Katherine I., et al.. (2025). Real world efficacy and safety of ivosidenib in US veterans with IDH1 mutated cholangiocarcinoma.. Journal of Clinical Oncology. 43(16_suppl). 4086–4086.

Zhao, Qiuhong, Chenyu Lin, Monalisa Ghosh, et al.. (2024). Siltuximab for chimeric antigen receptor T-cell therapy–related CRS and ICANS: a multicenter retrospective analysis. Blood Advances. 9(1). 170–175. 12 indexed citations

Lin, Chenyu, Anand Patel, Dezheng Huo, et al.. (2024). A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis. Blood Advances. 8(22). 5735–5743. 1 indexed citations

Murthy, Guru Subramanian Guru, Talha Badar, Annie Im, et al.. (2024). Impact of Time from Diagnosis to Treatment on Outcomes of Adults with AML Treated with HMA and Venetoclax: A US-Based, Multi-Center, Real-World, Retrospective Analysis from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND). Blood. 144(Supplement 1). 447–447. 1 indexed citations

Wang, Mei, et al.. (2024). Impact of eligibility criteria discordance on clinical trial accrual in diffuse large B-cell lymphoma (DLBCL).. Journal of Clinical Oncology. 42(16_suppl). e13707–e13707.

Makokha, Anselimo, et al.. (2024). Nutritional metabolite accumulation and transcription of selected biosynthesis genes in response to drought stress in leaf amaranth (Amaranthus sp.). Scientific African. 27. e02526–e02526.

Zhou, Katherine I., Chenyu Lin, Chin‐Lin Tseng, et al.. (2024). Brief Report: Real-World Efficacy and Safety of Sotorasib in U.S. Veterans with KRAS G12C-Mutated NSCLC. JTO Clinical and Research Reports. 5(5). 100670–100670. 3 indexed citations

Lee, Michelle, W. Vaughn McCall, Joanna Cwykiel, et al.. (2024). Real-World Treatment Patterns and Effectiveness of Midostaurin Versus Quizartinib in FLT3-ITD Mutated Acute Myeloid Leukemia Undergoing Intensive Induction. Blood. 144(Supplement 1). 4282–4282. 1 indexed citations

Lin, Chenyu, et al.. (2023). Impact of Social Determinants of Health and Novel Therapies on the Outcomes of Relapsed and Refractory Diffuse Large B Cell Lymphoma. Blood. 142(Supplement 1). 2396–2396.

10.

Lin, Chenyu & Hung‐Jen Chien. (2023). Acute exacerbation of ocular graft-versus-host disease and anterior uveitis after COVID-19 vaccination. BMC Ophthalmology. 23(1). 360–360. 1 indexed citations

11.

Zhou, Katherine I., Chenyu Lin, Jadee Neff, & Ahmed Galal. (2023). Dasatinib-associated follicular lymphoma in a patient with B-cell acute lymphoblastic leukaemia. BMJ Case Reports. 16(5). e252739–e252739. 1 indexed citations

12.

Roloff, Gregory W., Rawan Faramand, Ibrahim Aldoss, et al.. (2023). Outcomes following brexucabtagene autoleucel administered as an FDA-approved therapy for adults with relapsed/refractory B-ALL.. Journal of Clinical Oncology. 41(16_suppl). 7001–7001. 8 indexed citations

13.

Lin, Chenyu, Gautam Sajeev, Patrick J. Stiff, et al.. (2022). Health-Related Quality of Life Following Allogeneic Hematopoietic Cell Transplantation with Omidubicel versus Umbilical Cord Blood. Transplantation and Cellular Therapy. 29(1). 52.e1–52.e9. 3 indexed citations

14.

Huang, Xin, Qian Chen, Xin Li, et al.. (2021). CKAP4 Antibody-Conjugated Si Quantum Dot Micelles for Targeted Imaging of Lung Cancer. Nanoscale Research Letters. 16(1). 124–124. 13 indexed citations

15.

Lin, Chenyu, Edwin P. Alyea, Taewoong Choi, et al.. (2021). Allogeneic Stem Cell Transplantation with Omidubicel: Long-Term Follow-up from a Single Center. Blood. 138(Supplement 1). 1827–1827. 1 indexed citations

16.

Gerratana, Lorenzo, Andrew A. Davis, Maurizio Polano, et al.. (2020). Understanding the organ tropism of metastatic breast cancer through the combination of liquid biopsy tools. European Journal of Cancer. 143. 147–157. 36 indexed citations

17.

Gerratana, Lorenzo, Andrew A. Davis, Ami N. Shah, et al.. (2019). Emerging Role of Genomics and Cell-Free DNA in Breast Cancer. Current Treatment Options in Oncology. 20(8). 68–68. 13 indexed citations

18.

Fan, Kang‐Hsing, Chenyu Lin, Chung‐Jan Kang, et al.. (2007). Combined-modality treatment for advanced oral tongue squamous cell carcinoma. International Journal of Radiation Oncology*Biology*Physics. 67(2). 453–461. 50 indexed citations

19.

Lin, Chenyu, et al.. (2005). Primary testicular actinomycosis mimicking metastatic tumor. International Journal of Urology. 12(5). 519–521. 5 indexed citations

20.

Pao, C C, et al.. (1997). Detection of human papillomavirus mRNA and cervical cancer cells in peripheral blood of cervical cancer patients with metastasis.. Journal of Clinical Oncology. 15(3). 1008–1012. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact